Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function.
D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D002417:Cattle; D003000:Clonidine / Q000378:metabolism; D004088:Dihydroergotoxine / Q000378:metabolism*; D004146:Dioxanes / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D066298:In Vitro Techniques; D007217:Indoramin / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D009928:Organ Specificity; D010647:Phenyl Ethers / Q000378:metabolism; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D010647:Phenyl Ethers; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D007217:Indoramin; D004088:Dihydroergotoxine; D003000:Clonidine; D009638:Norepinephrine; D004837:Epinephrine